INM Stock Analysis: Buy, Sell, or Hold?
INM - InMed Pharmaceuticals Inc. Common Shares
$0.65
0.02 (2.54%)
▲
5d:
-6.65%
30d:
-8.75%
90d:
-26.96%
HOLD
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Get Alerted When INM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: INM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: INM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: INM is currently trading at $0.65, which is considered oversold relative to its 30-day fair value range of $0.66 to $0.74.
Technical Outlook: Technically, INM is in a strong downtrend. Immediate support is located at $0.62, while resistance sits at $0.81.
Market Sentiment: INM has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $20.00 (+2976.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, INM is in a strong downtrend. Immediate support is located at $0.62, while resistance sits at $0.81.
Market Sentiment: INM has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $20.00 (+2976.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.66 -
$0.74
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 2976.4% below Wall St target ($20.00)
- CAUTION: 5-day price weakness (-6.6%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.66 -
$0.74
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.62
Resistance Level
$0.81
Current Trend
Strong Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Wall Street Target
$20.00
(+2976.4%)
Revenue Growth (YoY)
-26.2%
Profit Margin
-172.2%
Share & Embed Analysis
Last updated: May 15, 2026 9:11 AM ET
Data refreshes hourly during market hours. Next update: 10:11 AM
Data refreshes hourly during market hours. Next update: 10:11 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$191 | 62 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$136 | 60 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$102 | 59 HOLD |
|
AQST
Aquestive Therapeutics I… |
STRONG BUY
9 analysts |
$9 | 65 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 56 HOLD |
